残余胆固醇升高改善缺血性卒中合并营养不良患者预后:基于队列研究
本前瞻性队列研究纳入5257例缺血性卒中患者,按控制营养状况评分分组,探讨基线残余胆固醇与3个月不良预后及全因死亡的关系。结果显示,残余胆固醇升高仅在任何程度营养不良患者中为独立保护因素,非营养不良患者中未见此关联。
要点
- 中重度营养不良患者不良预后风险最高(61.3%),全因死亡风险最高(32.8%)。
- 残余胆固醇升高仅在任何程度营养不良患者中为独立保护因素(P<0.05)。
- 非营养不良患者中未观察到残余胆固醇升高与不良预后的保护性关联。
核心结论
- 脂质悖论仅见于营养不良的缺血性卒中患者,残余胆固醇升高在该人群中为独立保护因素。
研究设计与样本
- 单中心前瞻性队列研究(中国上海),2018年1月至2022年12月,最终纳入5257例缺血性卒中患者。
主要发现
- 中重度营养不良患者不良预后198例(61.3%),全因死亡106例(32.8%),风险最高(P<0.001)。
- 残余胆固醇升高仅在任何程度营养不良患者中为独立保护因素(P<0.05),非营养不良患者中未观察到。
- 以中重度营养不良且残余胆固醇<0.471 mmol/L为参照,残余胆固醇0.633-0.868 mmol/L组不良预后调整OR为0.259(95%CI 0.095-0.704),全因死亡调整OR为0.222(95%CI 0.061-0.810)。
- 残余胆固醇≥0.869 mmol/L组不良预后调整OR为0.160(95%CI 0.037-0.689),全因死亡调整OR为0.202(95%CI 0.042-0.967)。
- 残余胆固醇0.471-0.632 mmol/L组不良预后调整OR为0.805(95%CI 0.450-1.438),全因死亡调整OR为0.898(95%CI 0.502-1.607)。
临床怎么用
- 非营养不良的缺血性卒中患者仍推荐严格降脂治疗。
- 治疗任何营养不良风险的缺血性卒中患者时,改善营养状态可能更为关键。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The mechanism of the lipid paradox remains uncertain, and malnutrition may be 1 explanation. In this prospective cohort study, we explored the associations between baseline remnant cholesterol (RC) concentrations and clinical outcomes in patients with ischemic stroke, stratified by nutritional status. METHODS: Patients with ischemic stroke in a single-center prospective cohort (Shanghai, China) from January 2018 to December 2022 were studied. Individuals were classified into 3 groups based on their Controlling Nutritional Status score. Poor outcome and all-cause mortality during up to 3 months of follow-up were compared among patients with varied nutritional status and RC levels utilizing multivariate logistic regression analyses, RC splines, and subgroup analyses. RESULTS: A total of 6892 patients with ischemic stroke were enrolled in the cohort, of which 5257 patients were included in the present study (without malnutrition: 2418 [46.0%]; mild malnutrition: 2516 [47.9%]; moderate-severe malnutrition: 323 [6.1%]). The median age was 69±12 years, and 3398 (64.6%) were men. Patients with moderate-severe malnutrition had the highest risks of poor outcome (198 [61.3%]; P<0.001) and all-cause mortality (106 [32.8%]; P<0.001) during the 3-month follow-up. A higher baseline RC level was an independent protective factor for adverse outcomes in patients with any degree of malnutrition (P<0.05), which was not observed in patients without malnutrition. In addition, compared with the moderate-severely malnourished with RC <0.471 mmol/L, the adjusted odds ratios for poor outcome and all-cause mortality were 0.805 (95% CI, 0.450-1.438) and 0.898 (0.502-1.607) for participants with 0.471 to 0.632 mmol/L, 0.259 (0.095-0.704) and 0.222 (0.061-0.810) for 0.633 to 0.868 mmol/L, and 0.160 (0.037-0.689) and 0.202 (0.042-0.967) for ≥0.869 mmol/L, respectively. CONCLUSIONS: The lipid paradox was only observed in the malnourished patients with ischemic stroke. Strict lipid reduction therapy is still recommended for patients without malnutrition. However, when treating patients at any risk of malnutrition, the improvement of nutritional status may be more crucial.
引用
- Niu H, Wang Y, Yang N, et al. Elevated Remnant Cholesterol Improves the Prognosis of Patients With Ischemic Stroke and Malnutrition: A Cohort-Based Study. Stroke. 2025. PMID: 40326332. doi:10.1161/STROKEAHA.124.048785
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。